Sep 13, 2021 InMed Pharmaceuticals has entered into an agreement to acquire BayMedica .

InMed Pharmaceuticals based at Vancouver, British Columbia, Canada.
“InMed is developing cannabinoid-based medications for diseases with high unmet needs. InMed is the leader in the therapeutic development of cannabinol, CBN.”

Acquirer’s Website: http://www.inmedpharma.com

BayMedica based at Incline Village, Nevada, United States. “BayMedica is a scalable biosynthetic platform delivering natural cannabinoids including CBC, CBD and CBG as well as novel cannabinoid analogs.”

Acquiree’s Website: http://www.baymedica.com